ImmunityBio, Inc. today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve ...

ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

New research has found that the benefits of graded sensorimotor retraining are likely to be similar for all patients with ...

Vestibular rehabilitation was associated with an impact on dizziness in vestibular migraine, but more detailed research is needed to fully investigate its efficacy, results of a literature review and ...

New exploratory findings demonstrate that in responders with IGFBP7 biomarker decline, CNM-Au8 30mg was strongly associated ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

Weight management medications show limited long-term effects, with rapid weight regain post-treatment, emphasizing the need ...

Detailed price information for Turn Therapeutics Inc (TTRX-Q) from The Globe and Mail including charting and trades.

The review looked at more than three dozen studies and found no evidence that acetaminophen increased the risk of ...

ANKTIVA® plus checkpoint inhibitor (CPI) therapy demonstrated statistically significant immune restoration across two ...

Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...